Insider · CIK 0001584759

Heyman Richard A.

CIK 0001584759 Name as filed on the most recent filing

Filed as Heyman Richard A. (31)

62 transaction lines · from 31 filings · filed 2021-04-05 to 2026-07-28 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

62 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-07-24 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 2 lines 157,462, disposed Open Form 4 filing 0001584759-26-000015
2026-07-06 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 3,600, disposed Open Form 4 filing 0001584759-26-000012
2026-02-17 S, Open-market sale Enliven Therapeutics, Inc.ELVN 32,196, disposed Open Form 4 filing 0001584759-26-000009
2026-01-20 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 32,902, disposed Open Form 4 filing 0001584759-26-000007
2026-01-16 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 2 lines 80,431, disposed Open Form 4 filing 0001584759-26-000006
2026-01-09 S, Open-market sale Enliven Therapeutics, Inc.ELVN 107,125, disposed Open Form 4 filing 0001584759-26-000004
2026-01-08 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 241,156, disposed Open Form 4 filing 0001584759-26-000004
2024-10-18 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 47,104, disposed Open Form 4 filing 0001415889-24-025500
2024-10-15 S, Open-market sale Enliven Therapeutics, Inc.ELVN 35,143, disposed Open Form 4 filing 0001415889-24-025381
2024-10-04 S, Open-market sale Enliven Therapeutics, Inc.ELVN 77,704, disposed Open Form 4 filing 0001415889-24-024899
2024-10-01 S, Open-market sale Enliven Therapeutics, Inc.ELVN 14,264, disposed Open Form 4 filing 0001415889-24-024668
2024-09-16 S, Open-market sale Enliven Therapeutics, Inc.ELVN 28,458, disposed Open Form 4 filing 0001415889-24-023610
2024-08-15 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 29,526, disposed Open Form 4 filing 0001415889-24-021644
2024-07-31 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 64,663, disposed Open Form 4 filing 0001415889-24-020685
2024-07-15 S, Open-market sale Enliven Therapeutics, Inc.ELVN 31,497, disposed Open Form 4 filing 0001415889-24-019731
2024-06-17 S, Open-market sale Enliven Therapeutics, Inc.ELVN 27,278, disposed Open Form 4 filing 0001415889-24-017715
2024-05-16 S, Open-market sale Enliven Therapeutics, Inc.ELVN 30,150, disposed Open Form 4 filing 0001415889-24-013833
2024-04-15 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 25,383, disposed Open Form 4 filing 0001415889-24-010825
2024-04-11 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 142,504, disposed Open Form 4 filing 0001415889-24-010825
2024-03-19 S, Open-market sale Enliven Therapeutics, Inc.ELVN 18,419, disposed Open Form 4 filing 0001415889-24-008883
2024-02-15 S, Open-market sale Enliven Therapeutics, Inc.ELVN 22,117, disposed Open Form 4 filing 0001415889-24-004495
2024-01-30 S, Open-market sale Enliven Therapeutics, Inc.ELVN 20,840, disposed Open Form 4 filing 0001415889-24-002220
2023-12-22 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 2,639, disposed Open Form 4 filing 0001209191-23-059715
2023-12-21 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 169, disposed Open Form 4 filing 0001209191-23-059715
2023-12-20 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 52,412, disposed Open Form 4 filing 0001209191-23-059431
2023-12-19 S, Open-market sale Enliven Therapeutics, Inc.ELVN 3,315, disposed Open Form 4 filing 0001209191-23-059431
2021-09-15 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 17,074, disposed Open Form 4 filing 0001209191-21-056461
2021-09-14 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 17,686, disposed Open Form 4 filing 0001209191-21-056461
2021-09-13 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 15,033, disposed Open Form 4 filing 0001209191-21-055871
2021-09-10 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 12,023, disposed Open Form 4 filing 0001209191-21-055871
2021-09-07 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 27,272, disposed Open Form 4 filing 0001209191-21-055295
2021-06-01 S, Open-market sale PMV Pharmaceuticals, Inc.PMVP 44,754, disposed Open Form 4 filing 0001209191-21-037144
2021-06-01 S, Open-market sale PMV Pharmaceuticals, Inc.PMVP 24,563, disposed Open Form 4 filing 0001209191-21-037144
2021-06-01 S, Open-market sale PMV Pharmaceuticals, Inc.PMVP 23,896, disposed Open Form 4 filing 0001209191-21-037144
2021-06-01 S, Open-market sale PMV Pharmaceuticals, Inc.PMVP 18,587, disposed Open Form 4 filing 0001209191-21-037144
2021-06-01 S, Open-market sale PMV Pharmaceuticals, Inc.PMVP 7,762, disposed Open Form 4 filing 0001209191-21-037144
2021-06-01 S, Open-market sale PMV Pharmaceuticals, Inc.PMVP 7,062, disposed Open Form 4 filing 0001209191-21-037144
2021-06-01 S, Open-market sale PMV Pharmaceuticals, Inc.PMVP 173, disposed Open Form 4 filing 0001209191-21-037144

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 62
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Heyman Richard A., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001584759

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.